Clinical Trial Update: The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy [NA]

View source ↗

Summary

Completed clinical trial evaluating riboflavin/UVA corneal cross-linking for the signs and symptoms of bullous keratopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Keratopathy

Drugs mentioned

• Riboflavin/UVA corneal cross-linking (riboflavin with ultraviolet-A light cross-linking)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Bullous Keratopathy | NA | Status: COMPLETED